175 related articles for article (PubMed ID: 25406210)
1. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.
Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210
[TBL] [Abstract][Full Text] [Related]
2. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
4. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
[TBL] [Abstract][Full Text] [Related]
5. [Primary ectopic intraosseous meningioma associated with multiple meningioma in a patient with central neurofibromatosis].
Poptodorov G; Gabrovski S; Kamenova M; Nacheva M; Iordanov I; Shirov T; Petkov R; Dŭbov D
Khirurgiia (Sofiia); 2006; (4-5):64-7. PubMed ID: 18843923
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
9. Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
Abi Jaoude S; Peyre M; Degos V; Goutagny S; Parfait B; Kalamarides M
J Neurosurg; 2020 May; 134(5):1377-1385. PubMed ID: 32442973
[TBL] [Abstract][Full Text] [Related]
10. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
11. Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders.
Mills JR; Moyer AM; Kipp BR; Poplawski AB; Messiaen LM; Babovic-Vuksanovic D
Clin Genet; 2018 Jan; 93(1):187-190. PubMed ID: 28737257
[TBL] [Abstract][Full Text] [Related]
12. Paediatric presentation of type 2 neurofibromatosis.
Evans DG; Birch JM; Ramsden RT
Arch Dis Child; 1999 Dec; 81(6):496-9. PubMed ID: 10569966
[TBL] [Abstract][Full Text] [Related]
13. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
[TBL] [Abstract][Full Text] [Related]
14. Clonality of multiple meningiomas.
Stangl AP; Wellenreuther R; Lenartz D; Kraus JA; Menon AG; Schramm J; Wiestler OD; von Deimling A
J Neurosurg; 1997 May; 86(5):853-8. PubMed ID: 9126902
[TBL] [Abstract][Full Text] [Related]
15. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
16. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
[TBL] [Abstract][Full Text] [Related]
17. Analysis of induced pluripotent stem cell clones derived from a patient with mosaic neurofibromatosis type 2.
Ishi Y; Era T; Yuzawa S; Okamoto M; Sawaya R; Motegi H; Yamaguchi S; Terasaka S; Houkin K; Fujimura M
Am J Med Genet A; 2022 Jun; 188(6):1863-1867. PubMed ID: 35178855
[TBL] [Abstract][Full Text] [Related]
18. Extracranial orbital meningioma extending into the nasosinus in neurofibromatosis type 2.
Yan J; Li Y
J Craniofac Surg; 2014 Mar; 25(2):664-6. PubMed ID: 24448521
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Hereditary Meningioma and Vestibular Schwannoma.
Shaw A
Recent Results Cancer Res; 2016; 205():17-27. PubMed ID: 27075346
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
